Rui qiang Xin

Dr. Rui qiang Xin

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2025 in Neurological Sciences
Verified
Journal Article
Open access
PDF file
JZJiali Zhong
Jiali Zhong
XJXiaoshan Jing
Xiaoshan Jing
YLYing Liang
Ying Liang
PHPan Hao
Pan Hao
RPRuchen Peng
Ruchen Peng
RXRui qiang Xin
Rui qiang Xin
Background: Post-stroke cognitive impairment (PSCI) is a common and severe consequence of ischemic stroke (IS) that significantly affects patient outcomes. Transcranial direct current stimulation (tDCS) has shown promise in enhancing cognitive function in IS patients, but its underlying mechanisms are not fully understood. This study investigates the effects of tDCS on brain functional connectivity and network topology using resting-state functional magnetic resonance imaging (rs-fMRI). Methods: In this double-blind study, sixty-five IS patients with PSCI were randomly assigned to either the tDCS or control group. Rs-fMRI data were acquired before and after the intervention. We analyzed functional connectivity (FC) and graph theory-based topological properties. Cognitive performance was assessed using the Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA). Results after: treatment, both groups showed improvements in MMSE and MoCA scores, with the tDCS group demonstrating significantly greater improvements (p < 0.05). In the tDCS group, FC significantly increased between four pairs of brain regions (p < 0.05, FDR-corrected). Additionally, Global Efficiency (E g ) significantly improved (p < 0.05, FDR-corrected), and this improvement positively correlated with enhancements in MMSE scores (r = 0.403, p = 0.037). Conclusion: These findings suggest that tDCS improves cognitive function in PSCI by altering brain network connectivity and topological organization, providing neuroimaging evidence to support its therapeutic mechanisms.

18 December 2024 in Discover Oncology
Verified
Journal Article
Open access
PDF file
PHPan Hao
Pan Hao
RXRui qiang Xin
Rui qiang Xin
YLYancui Li
Yancui Li
XNXu Na
Xu Na
XLXiaoyong Lv
Xiaoyong Lv
Background This research utilized the bibliometrics method to analyze the published literature related to prostate cancer (PCa) imaging. Furthermore, current knowledge and research hotspots of radiomics in PCa diagnosis and treatment were comprehensively reviewed, as well as progress and emerging trends in field were explored. Methods In this investigation, the relevant literature on radiomics, and PCa was retrieved from Web of Science Core Collection (WoSCC) databases from 2000 and 2024. Furthermore, a comprehensive bibliometric analysis was carried out using advanced tools like CiteSpace6.2, VOS viewer, and the 'bibliometrix' package of R software to visualize the annual distribution of publications across various aspects such as authors, countries, journals, institutions, and keywords. Results This analysis included 593 from 58 countries including China and the United States. Chinese Academy of Sciences and Frontiers in Oncology were the institutions and journals that publish the most relevant articles, -while Radiology journal had the greatest number of co-cited publications. Furthermore, 3,621 authors published on this topic, of which Madabhushi Anant and Stoyanova Radka had the highest contributions. Moreover, Lambin, P. had the most co-citations. In addition, the diagnostic characteristics of radiomics in PCa imaging and treatment strategies are the current research focal points. The establishment of multi-functional imaging techniques and independent factor models warrants future investigation. Conclusions In summary, this analysis revealed that the research on PCa imaging is developing vigorously, focusing on the diagnostic methods and intervention measures of imaging in PCa diagnosis and treatment. In the future, there is an urgent need for improved collaboration and communication among countries and institutions.

4 August 2021 in Frontiers in Neurology
Verified
Journal Article
Open access
LCLipeng Cai
Lipeng Cai
GRGary Rajah
Gary Rajah
HDHonglian Duan
Honglian Duan
JGJie Gao
Jie Gao
Zhe ChengZhe Cheng
Zhe Cheng
Yuchuan DingYuchuan Ding
Yuchuan Ding
Background: Despite intravenous thrombolysis and endovascular therapy for acute ischemic stroke (AIS), many survivors still have varying degrees of disability. Glyceryl trinitrate (GTN), a nitric oxide (NO) donor, has been previously reported to induce neuroprotection after AIS. The use of GTN to reduce brain damage after stroke remains yet to be elucidated. This study was designed to explore the safety, feasibility, and preliminary efficacy of intravenous administration of GTN after AIS.Methods: A prospective randomized controlled trial is proposed with AIS patients. Participants will be randomly allocated to GTN group and control group with a 1:1 ratio (n = 40). Both groups will be treated with standard therapies according to the current stroke guidelines. Participants allocated to the GTN group will receive intravenous administration of GTN (5 mg GTN in 50 ml saline at a rate of 0.4 mg/h that is continued for 12.5 h/day for 2 days) within 24 h of symptom onset. Participants allocated to the control group will receive intravenous administration at equal capacity of 0.9% normal saline (NS) (total 50 ml/day at 4 ml/h that is continued for 12.5 h/day for 2 days). The primary outcome is safety [systolic blood pressure (SBP) <110 mmHg, headache], while the secondary outcomes include changes in functional outcome and infarction volume.Discussion: Rapid Intravenous Glyceryl Trinitrate in Ischemic Damage (RIGID) is a prospective randomized controlled trial that aims to ascertain the safety, feasibility, and preliminary efficacy of intravenous GTN as a neuroprotection strategy after AIS. These results will provide parameters for future studies as well as provide insights into treatment effects. Any possible neuroprotective qualities of GTN in AIS will also be elucidated.Trial Registration:www.chictr.org.cn, identifier: ChiCTR2100046271.

29 December 2024 in Journal of International Medical Research
Verified
Journal Article
Open access
PHPan Hao
Pan Hao
RXRui qiang Xin
Rui qiang Xin
RPRuchen Peng
Ruchen Peng
YLYancui Li
Yancui Li
XNXu Na
Xu Na
LSLixin Sun
Lixin Sun
Objective: We aimed to evaluate the diagnostic utility of 3.0-T magnetic resonance (MR) diffusion-weighted imaging (DWI)-derived apparent diffusion coefficient (ADC) values in conjunction with clinical indices for prostate cancer (PCa). Methods: A retrospective analysis was conducted on the clinical data of 181 patients with suspected PCa who underwent MR DWI prior to biopsy at LuHe Hospital, Beijing, between February 2022 and July 2023. Patients were placed into Malignancy and Benign groups according to the biopsy results. Univariate and multivariate analyses were performed on the ADC values and clinical indicators, and then a combination predictive model was developed. The model’s diagnostic accuracy was assessed using receiver operating characteristic (ROC) curve and decision curves analysis (DCA), and a nomogram was constructed for the assessment of individual risk. Results: The ADC value and the free prostate-specific antigen and total prostate-specific antigen (tPSA) levels were found to be independent predictors of PCa. tPSA showed the best diagnostic performance, with an area under the curve (AUC) of 0.914. However, the combined model had a higher diagnostic accuracy, with an AUC of 0.959. Conclusion: The combined model has superior predictive performance to other diagnostic methods and should help with the avoidance of unnecessary prostate biopsies.

27 December 2025 in Neuroradiology
Verified
Journal Article
Open access
PDF file
RGRan Guo
Ran Guo
XQXiaoxia Qu
Xiaoxia Qu
STSong Tian
Song Tian
ZLZheng Li
Zheng Li
XWXinyan Wang
Xinyan Wang
JXJunfang Xian
Junfang Xian
Background Pretreatment determination of histological differentiation grade is critical for prognostic evaluation in laryngeal and hypopharyngeal squamous cell carcinoma (LHSCC). This study aimed to develop a contrast-enhanced CT (CECT)-based Vision Transformer (ViT) model for noninvasive evaluation of histological grades in LHSCC. Methods In this retrospective multicenter study, a total of 1,648 LHSCC patients who underwent CECT scans were enrolled from three hospitals in this study. Participants were divided into a training cohort (n = 1,239), an internal validation cohort (n = 310) from one hospital, and an external validation cohort (n = 99) from the other two hospitals. The diagnostic model integrates a pre-trained ViT for CECT feature extraction and an XGBoost classifier for prediction. The model’s predictive performance was evaluated using the area under the curve (AUC), decision curve analysis (DCA), and calibration curve. Results The ViT model achieved AUCs of 0.887 (95%CI: 0.848–0.927) in internal validation and 0.796 (95%CI: 0.693–0.899) in external validation cohorts, significantly outperforming the conventional radiomics model (AUCs: 0.775, 95%CI: 0.714–0.837 and 0.544, 95%CI: 0.388–0.699; p < 0.001 and 0.002, respectively). Clinically, DCA demonstrated superior clinical utility, while calibration curves showed excellent prediction reliability. Gradient-weighted Class Activation Mapping visualization identified CT image regions most influential for the model’s predictions, providing interpretability for clinical decision-making. Conclusion The ViT-based deep learning model developed in this study using CECT demonstrated excellent predictive performance for histological grading of LHSCC, with promising application for patient prognosis assessment.

1 December 2025 in Journal of Research in Medical Sciences
Verified
Journal Article
Open access
PHPan Hao
Pan Hao
RXRui qiang Xin
Rui qiang Xin
YLYancui Li
Yancui Li
RGRan Guo
Ran Guo
LSLixin Sun
Lixin Sun
MJMin Jia
Min Jia
Background: To investigate the risk factors of preoperative bone metastasis (BM) of prostate cancer (PCa) by using semi-quantitative single-photon emission computed tomography/computed tomography (SPECT/CT) whole-body bone imaging and peripheral blood biomarkers, and to establish a morphological map model to evaluate its prediction accuracy. Materials and Methods: Clinical data of 220 patients diagnosed with PCa were retrospectively analyzed. BM was identified using SPECT/CT. Based on the presence or absence of BM, patients were divided into two groups. Univariate and multiple logistic regression analyses were performed on various factors, including age, laboratory parameters, prostate volume determined, clinical tumor stage (cTx), and Gleason score (GS). Draw the receiver operating characteristic curve and calculate the area under the curve (AUC), and analyze the predictive efficacy. In addition, we construct a nomogram representing the BM prediction model using clinical data and generate a calibration plot to assess the accuracy of our predictions. Results: The analysis of univariate and multiple logistic regression demonstrated that (target area-nontarget area)/nontarget area (T-NT)/NT, alkaline phosphatase (ALP), total prostate-specific antigen (tPSA), cTx, and GS were independent predictors of BM in PCa. The tPSA displayed the highest AUC of 0.68 (95% confidence interval [CI]: 0.62–0.75) among the five independent predictors. The best predictive efficacy was shown when the predictive model was established using these five factors, as evidenced by the AUC of 0.80 (95% CI: 0.75–0.86) being higher than any single indicator. The predictive model’s external validation data sensitivity and specificity metrics were 66.67% (8/12) and 95.65% (22/23), respectively, which were consistent with the model’s initial sensitivity of 58.02% and specificity of 87.77%, indicating high accuracy and stability. Conclusion: The established predictive model, incorporating (T-NT)/NT from semi-quantitative SPECT/CT, ALP, tPSA, cTx, and GS, exhibits strong predictive efficacy with high accuracy and stability, providing a reliable tool for preoperative assessment of BM risk in PCa patients.